A path forward for the chlamydial virulence factor CPAF

Microbes and Infection

Volumn 15, Issue 14-15, 2013, Pages 1026-1032

  Conrad, Turner A ^a   Yang, Zhangsheng ^a   Ojcius, David ^b   Zhong, Guangming ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydial virulence factors and pathogenesis; CPAF; Substrates

Indexed keywords

ANTIGEN; BACTERIAL PROTEIN; BACTERIAL VACCINE; MESYLIC ACID ETHYL ESTER; PROTEASOME; PROTEIN CPAF; PROTEINASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CHLAMYDIA; CHLAMYDIASIS; DRUG MECHANISM; ENZYME CONFORMATION; ENZYME SUBSTRATE; GENE MUTATION; HOST RESISTANCE; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SEROTYPE; UROGENITAL TRACT INFECTION;

CHLAMYDIALES;

CHLAMYDIAL VIRULENCE FACTORS AND PATHOGENESIS; CPAF; SUBSTRATES;

ANIMALS; CHLAMYDIA; ENDOPEPTIDASES; HUMANS; VIRULENCE FACTORS;

EID: 84889094466     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2013.09.008     Document Type: Article

References (61)

1. Zhong G., Fan P., Ji H., Dong F., Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 2001, 193:935-942.
2. Dong F., Pirbhai M., Zhong Y., Zhong G. Cleavage-dependent activation of a chlamydia-secreted protease. Mol. Microbiol. 2004, 52:1487-1494.
3. Dong F., Sharma J., Xiao Y., Zhong Y., Zhong G. Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors. Infect. Immun. 2004, 72:3869-3875.
4. Dong F., Zhong Y., Arulanandam B., Zhong G. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species. Infect. Immun. 2005, 73:1868-1872.
5. Chen D., Lei L., Flores R., Huang Z., Wu Z., Chai J., Zhong G. Autoprocessing and self-activation of the secreted protease CPAF in Chlamydia-infected cells. Microb. Pathog. 2010, 49:164-173.
6. Chen D., Chai J., Hart P.J., Zhong G. Identifying catalytic residues in CPAF, a Chlamydia-secreted protease. Arch. Biochem. Biophys. 2009, 485:16-23.
7. Huang Z., Feng Y., Chen D., Wu X., Huang S., Wang X., Xiao X., Li W., Huang N., Gu L., Zhong G., Chai J. Structural basis for activation and inhibition of the secreted chlamydia protease CPAF. Cell Host Microbe 2008, 4:529-542.
8. Wang S.P., Grayston J.T. Serotyping of Chlamydia trachomatis by indirect fluorescent-antibody staining of inclusions in cell culture with monoclonal antibodies. J. Clin. Microbiol. 1991, 29:1295-1298.
9. Stary G., Stary A. Lymphogranuloma venereum outbreak in Europe. J. Dtsch Dermatol. Ges. 2008, 6:935-940.
10. Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 1995, 8:451-461.
11. Stewardson A.J., Grayson M.L. Psittacosis. Infect. Dis. Clin. North Am. 2010, 24:7-25.
12. Sherman K.J., Daling J.R., Stergachis A., Weiss N.S., Foy H.M., Wang S.P., Grayston J.T. Sexually transmitted diseases and tubal pregnancy. Sex Transm. Dis. 1990, 17:115-121.
13. O'Connell C.M., Ingalls R.R., Andrews C.W., Scurlock A.M., Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 2007, 179:4027-4034.
14. Kari L., Whitmire W.M., Olivares-Zavaleta N., Goheen M.M., Taylor L.D., Carlson J.H., Sturdevant G.L., Lu C., Bakios L.E., Randall L.B., Parnell M.J., Zhong G., Caldwell H.D. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J. Exp. Med. 2011, 208:2217-2223.
15. Li Z., Zhong Y., Lei L., Wu Y., Wang S., Zhong G. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol. 2008, 8:90.
16. Wang J., Zhang Y., Lu C., Lei L., Yu P., Zhong G. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J. Immunol. 2010, 185:1670-1680.
17. Li Z., Chen D., Zhong Y., Wang S., Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect. Immun. 2008, 76:3415-3428.
18. Song L., Carlson J.H., Whitmire W.M., Kari L., Virtaneva K., Sturdevant D.E., Watkins H., Zhou B., Sturdevant G.L., Porcella S.F., McClarty G., Caldwell H.D. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect. Immun. 2013, 81:636-644.
19. Carlson J.H., Whitmire W.M., Crane D.D., Wicke L., Virtaneva K., Sturdevant D.E., Kupko J.J., Porcella S.F., Martinez-Orengo N., Heinzen R.A., Kari L., Caldwell H.D. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect. Immun. 2008, 76:2273-2283.
20. Sturdevant G.L., Kari L., Gardner D.J., Olivares-Zavaleta N., Randall L.B., Whitmire W.M., Carlson J.H., Goheen M.M., Selleck E.M., Martens C., Caldwell H.D. Frameshift mutations in a single novel virulence factor alter the invivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect. Immun. 2010, 78:3660-3668.
21. Samudrala R., Heffron F., McDermott J.E. Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. PLoS Pathog. 2009, 5:e1000375.
22. Fields K.A., Hackstadt T. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol. Microbiol. 2000, 38:1048-1060.
23. Bao X., Nickels B.E., Fan H. Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of sigma66. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:16870-16875.
24. Zhong G. Chlamydia trachomatis secretion of proteases for manipulating host signaling pathways. Front Microbiol. 2011, 2:14.
25. Wu X., Lei L., Gong S., Chen D., Flores R., Zhong G. The chlamydial periplasmic stress response serine protease cHtrA is secreted into host cell cytosol. BMC Microbiol. 2011, 11:87.
26. Hobolt-Pedersen A.S., Christiansen G., Timmerman E., Gevaert K., Birkelund S. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. FEMS Immunol. Med. Microbiol. 2009, 57:46-58.
27. Gong S., Lei L., Chang X., Belland R., Zhong G. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Microbiology 2011, 157:1134-1144.
28. Lei L., Dong X., Li Z., Zhong G. Identification of a novel nuclear localization signal sequence in Chlamydia trachomatis-secreted hypothetical protein CT311. PLoS One 2013, 8:e64529.
29. Lei L., Qi M., Budrys N., Schenken R., Zhong G. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Microb. Pathog. 2011, 51:101-109.
30. Qi M., Lei L., Gong S., Liu Q., DeLisa M.P., Zhong G. Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. J. Bacteriol. 2011, 193:2498-2509.
31. Lu C., Lei L., Peng B., Tang L., Ding H., Gong S., Li Z., Wu Y., Zhong G. Chlamydia trachomatis GlgA is secreted into host cell cytoplasm. PLoS One 2013, in press.
32. Qi M., Gong S., Lei L., Liu Q., Zhong G. A Chlamydia trachomatis OmcB C-terminal fragment is released into the host cell cytoplasm and is immunogenic in humans. Infect. Immun. 2011, 79:2193-2203.
33. Zhong G. Killing me softly: chlamydial use of proteolysis for evading host defenses. Trends Microbiol. 2009, 17:467-474.
34. Christian J.G., Heymann J., Paschen S.A., Vier J., Schauenburg L., Rupp J., Meyer T.F., Hacker G., Heuer D. Targeting of a chlamydial protease impedes intracellular bacterial growth. PLoS Pathog. 2011, 7:e1002283.
35. Heuer D., Rejman Lipinski A., Machuy N., Karlas A., Wehrens A., Siedler F., Brinkmann V., Meyer T.F. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 2009, 457:731-735.
36. Fischer S.F., Vier J., Kirschnek S., Klos A., Hess S., Ying S., Hacker G. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J. Exp. Med. 2004, 200:905-916.
37. Jorgensen I., Bednar M.M., Amin V., Davis B.K., Ting J.P., McCafferty D.G., Valdivia R.H. The Chlamydia protease CPAF regulates host and bacterial proteins to maintain pathogen vacuole integrity and promote virulence. Cell Host Microbe 2011, 10:21-32.
38. Chen A.L., Johnson K.A., Lee J.K., Sutterlin C., Tan M. CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog. 2012, 8:e1002842.
39. Hou S., Lei L., Yang Z., Qi M., Liu Q., Zhong G. Chlamydia trachomatis outer membrane complex protein B (OmcB) is processed by the protease CPAF. J. Bacteriol. 2013, 195:951-957.
40. Sharma J., Bosnic A.M., Piper J.M., Zhong G. Human antibody responses to a Chlamydia-secreted protease factor. Infect. Immun. 2004, 72:7164-7171.
41. Sharma J., Zhong Y., Dong F., Piper J.M., Wang G., Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect. Immun. 2006, 74:1490-1499.
42. Lu C., Holland M.J., Gong S., Peng B., Bailey R.L., Mabey D.W., Wu Y., Zhong G. Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis. Invest Ophthalmol. Vis. Sci. 2012, 53:2551-2559.
43. Skwor T., Kandel R.P., Basravi S., Khan A., Sharma B., Dean D. Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma. Invest Ophthalmol. Vis. Sci. 2010, 51:5128-5136.
44. Sharma J., Dong F., Pirbhai M., Zhong G. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis. Infect. Immun. 2005, 73:4414-4419.
45. Murthy A.K., Cong Y., Murphey C., Guentzel M.N., Forsthuber T.G., Zhong G., Arulanandam B.P. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect. Immun. 2006, 74:6722-6729.
46. Murphey C., Murthy A.K., Meier P.A., Neal Guentzel M., Zhong G., Arulanandam B.P. The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. Cell Immunol. 2006, 242:110-117.
47. Murthy A.K., Chambers J.P., Meier P.A., Zhong G., Arulanandam B.P. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production. Infect. Immun. 2007, 75:666-676.
48. Murthy A.K., Chaganty B.K., Li W., Guentzel M.N., Chambers J.P., Seshu J., Zhong G., Arulanandam B.P. A limited role for antibody in protective immunity induced by rCPAF and CpG vaccination against primary genital Chlamydia muridarum challenge. FEMS Immunol. Med. Microbiol. 2009, 55:271-279.
49. Murthy A.K., Guentzel M.N., Zhong G., Arulanandam B.P. Chlamydial protease-like activity factor - insights into immunity and vaccine development. J. Reprod. Immunol. 2009, 83:179-184.
50. Morrison R.P., Caldwell H.D. Immunity to murine chlamydial genital infection. Infect. Immun. 2002, 70:2741-2751.
51. Chen D., Lei L., Lu C., Flores R., DeLisa M.P., Roberts T.C., Romesberg F.E., Zhong G. Secretion of the chlamydial virulence factor CPAF requires the Sec-dependent pathway. Microbiology 2010, 156:3031-3040.
52. Griffiths E., Ventresca M.S., Gupta R.S. BLAST screening of chlamydial genomes to identify signature proteins that are unique for the Chlamydiales, Chlamydiaceae, Chlamydophila and Chlamydia groups of species. BMC Genomics 2006, 7:14.
53. Mashburn-Warren L.M., Whiteley M. Special delivery: vesicle trafficking in prokaryotes. Mol. Microbiol. 2006, 61:839-846.
54. Bomberger J.M., Maceachran D.P., Coutermarsh B.A., Ye S., O'Toole G.A., Stanton B.A. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 2009, 5:e1000382.
55. Matsumoto A., Manire G.P. Electron microscopic observations on the fine structure of cell walls of Chlamydia psittaci. J. Bacteriol. 1970, 104:1332-1337.
56. Jorgensen I., Valdivia R.H. Pmp-like proteins Pls1 and Pls2 are secreted into the lumen of the Chlamydia trachomatis inclusion. Infect. Immun. 2008, 76:3940-3950.
57. Giles D.K., Whittimore J.D., LaRue R.W., Raulston J.E., Wyrick P.B. Ultrastructural analysis of chlamydial antigen-containing vesicles everting from the Chlamydia trachomatis inclusion. Microbes Infect 2006, 8:1579-1591.
58. Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Clarke I.N. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011, 7:e1002258.
59. Gong S., Yang Z., Lei L., Shen L., Zhong G. Characterization of Chlamydia trachomatis plasmid-encoded open reading frames. J. Bacteriol. 2013, in press.
60. Kari L., Goheen M.M., Randall L.B., Taylor L.D., Carlson J.H., Whitmire W.M., Virok D., Rajaram K., Endresz V., McClarty G., Nelson D.E., Caldwell H.D. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:7189-7193.
61. Nguyen B.D., Valdivia R.H. Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1263-1268.